Coding Ahead
CasePilot
Medical Coding Assistant
CaseConsultant
Instant Email Coding Consultant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Noncontact near-infrared spectroscopy (NIRS) is a sophisticated imaging technique utilized primarily for the screening of peripheral artery disease (PAD). This method leverages the unique properties of near-infrared light, which can penetrate biological tissues with relative ease. The technique is particularly effective in measuring key parameters such as deoxyhemoglobin, oxyhemoglobin, and the overall ratio of tissue oxygenation. The significance of this procedure lies in its ability to identify symptomatic PAD, a condition that poses a considerable risk of functional decline and mobility loss in affected individuals. During the assessment, patients typically undergo provocative maneuvers, which may include activities like a six-minute walking test or a standard treadmill test, to elicit physiological responses that can be measured. A noncontact handheld imaging device is strategically positioned over the gastrocnemius muscle in one or both lower extremities. This device emits six distinct near-infrared electromagnetic wavelengths of light, which interact differently with oxygenated and deoxygenated hemoglobin molecules present in the muscle tissue. The light that is not absorbed is reflected back to the device, where it is recorded for analysis. Advanced proprietary software processes the return signal, calculating the oxygen saturation levels at each pixel and generating a visual representation akin to a color-coded map. This map, along with a comprehensive clinical report, provides critical insights into the presence and severity of PAD. Notably, lower extremities affected by PAD exhibit specific changes in muscle oxygenation, and the extent of deviation from normal oxygenation levels can serve as a predictive indicator of potential walking limitations for the patient.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The noncontact near-infrared spectroscopy procedure is indicated for the screening of peripheral arterial disease (PAD). This condition is characterized by reduced blood flow to the extremities, which can lead to significant mobility issues and functional decline. The procedure is particularly relevant for patients who exhibit symptoms suggestive of PAD, allowing for early detection and intervention.

  • Screening for Peripheral Arterial Disease (PAD) This procedure is performed to identify the presence of PAD in patients who may be at risk due to symptoms or other clinical indicators.

2. Procedure

The noncontact near-infrared spectroscopy procedure involves several key steps to ensure accurate measurement and assessment of tissue oxygenation.

  • Step 1: Patient Preparation The patient is prepared for the procedure by explaining the process and the need for provocative maneuvers, such as a six-minute walking test or a standard treadmill test. This preparation is crucial for ensuring that the patient understands the purpose of the test and what to expect during the procedure.
  • Step 2: Provocative Maneuver The patient is then asked to perform a provocative maneuver, which is designed to stimulate blood flow and elicit a physiological response. This may involve walking on a treadmill or completing a six-minute walking test, which helps to assess the functional capacity of the lower extremities.
  • Step 3: Imaging Device Positioning A noncontact handheld imaging device is positioned over the gastrocnemius muscle in one or both lower extremities. This device is specifically designed to emit near-infrared light and capture the reflected signals from the tissue.
  • Step 4: Light Emission and Data Capture The device emits six near-infrared electromagnetic wavelengths of light, which penetrate the muscle tissue. The light interacts with hemoglobin molecules, and the device captures the unabsorbed light that is reflected back. This data is critical for analyzing the oxygen saturation levels in the muscle.
  • Step 5: Data Analysis The captured light signals are processed by proprietary calculation software, which assesses the oxygen saturation levels at each pixel based on the return signal. This analysis results in a detailed visual representation, often displayed as a color-coded map, indicating the levels of oxygenation in the muscle tissue.
  • Step 6: Interpretation and Reporting Finally, the data is interpreted to generate a comprehensive report detailing the presence of PAD. The report includes insights into the characteristic changes in oxygenation observed in the calf muscle, which can help predict potential walking limitations for the patient.

3. Post-Procedure

After the noncontact near-infrared spectroscopy procedure, patients may receive guidance on the interpretation of their results and any necessary follow-up actions. The report generated will provide critical information regarding the presence and severity of peripheral arterial disease, which can inform further clinical decisions. Patients may be advised on lifestyle modifications, additional diagnostic testing, or treatment options based on the findings. It is essential for healthcare providers to discuss the implications of the results with the patient to ensure appropriate management of their condition.

Short Descr NCNTC IFR SPCTRSC SCR PAD
Medium Descr NCNTC NR IFR SPECTRSC SCR PAD W/PROV MANEUVERS
Long Descr Noncontact near-infrared spectroscopy (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation), for screening for peripheral arterial disease, including provocative maneuvers, image acquisition, interpretation, and report, one or both lower extremities
Status Code Non-Covered Service
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Non-Covered Service, not paid under OPPS
Berenson-Eggers TOS (BETOS) none
MUE 1
FS Split (or shared) evaluation and management visit
Date
Action
Notes
2024-01-01 Added Code Added.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"